Moderna to cut R&D expenses by $1.1B | Pharma Manufacturing

Moderna To Cut R&D Expenses By $1.1B | Pharma Manufacturing

2 weeks from now

Sep 12, 2024  · This week, Moderna outlined its R&D progress and cost-cutting strategy, aiming for 10 product approvals by 2027 while reducing expenses. To streamline operations, …

pharmamanufacturing.com

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs, Launch …

2 weeks from now

Sep 12, 2024  · Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

cnbc.com

JPM25: Moderna Slashes Guidance, Plots $1B In Cost Cuts This Year …

2 weeks from now

2 days ago  · The company has reduced its revenue guidance for 2025, as well, forecasting sales to land between $1.5 billion and $2.5 billion this year. The big biotech previously hoped to …

fiercepharma.com

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

4 days ago  · Moderna is showcasing its R&D pipeline to investors today, but the headline news is a decision to cut its R&D spend by a massive $1.1 billion a year from 2027, reversing years of …

pharmaphorum.com

Moderna To Cut R&D Spending $1.1 B - STAT

2 weeks from now

Sep 12, 2024  · Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who …

statnews.com

Moderna Crashes After Slashing Its R&D Budget By $1.1 Billion

2 weeks from now

Sep 16, 2024  · Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget by $1.1 billion and issued light 2025 sales guidance. The company says its investment …

investors.com

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs

2 weeks from now

Sep 12, 2024  · Moderna said Thursday that based on current trial data, it expects to receive Food and Drug Administration (FDA) approval for 10 new products over the next three years while …

investopedia.com

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

2 weeks from now

Sep 12, 2024  · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

StockWatch: Moderna's $1.1B R&D Cut, Profitability Delay Jolt …

2 weeks from now

Sep 16, 2024  · Over the next three years, Moderna added, it will cut about between $1 billion and $1.2 billion in expenses by shrinking its R&D budget by about 20%, going from the $4.8 billion …

genengnews.com

Moderna Cuts Five Programmes To Save $1.1bn In R&D Costs - MSN

2 weeks from now

In June, Moderna’s RSV vaccine mRESVIA secured US Food and Drug Administration (FDA) approval for adults over the age of 60. This marked the first approval of an mRNA vaccine for …

msn.com

Moderna To Slash Costs By $1.1B - LinkedIn

2 weeks from now

Sep 12, 2024  · Moderna, the biotech company known for developing one of the COVID-19 vaccines, plans to cut $1.1 billion in expenses by 2027 as it adjusts its business in the post …

linkedin.com

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

2 weeks from now

Sep 12, 2024  · Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. Rather than spending to explore new products, the …

kiplinger.com

Moderna Aims To Cut $1B In Expenses | Springfield Business Journal

2 weeks from now

Sep 12, 2024  · Moderna is seeking to cut $1.1 billion in expenses by 2027. Research and development spending is expected to be reduced to $3.6 billion to $3.8 billion, down from an …

sbj.net

Moderna, Trailing Rivals, Checks Its RSV Shot Expectations

2 weeks from now

Sep 13, 2024  · Moderna also disclosed cuts to research spending and the discontinuation of several pipeline projects. The biotech plans to reduce R&D spending by $1.1 billion annually …

biopharmadive.com

Moderna's Stock Slides As It Slashes Research Spending

2 weeks from now

Sep 12, 2024  · The biotech company said it is cutting its expected research-and-development expenses for 2025 through 2028 by 20%, to $16 billion for the period. ... Moderna said it aims …

morningstar.com

Moderna's Spending Cuts, Pipeline Shakeup Leave Doubts About A …

2 weeks from now

Sep 13, 2024  · The J.P. Morgan analysts downgraded Moderna's stock to underweight from neutral, and cut their price target to $70, from $88. Moderna's stock is down 33% in the year to …

morningstar.com

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024  · Moderna said it would cut $1.1 billion in expenses by 2027 and acknowledged that its individualized neoantigen therapy (INT) cancer treatment is unlikely to receive accelerated …

investopedia.com

Moderna To Cut Over $1 Billion By 2027, Aims For New Vaccine …

2 weeks from now

Sep 12, 2024  · Moderna projects 2025 revenue between $2.5 billion and $3.5 billion and expects a 25% annual growth rate as new products launch by 2026. ... Moderna to Cut Over $1 Billion …

msn.com